Gemcitabine/Nab-Paclitaxel and Pamrevlumab in Locally Advanced Pancreatic Cancer (LAPC): A Phase 1/2 Trial

2019 ◽  
Author(s):  
Vincent Picozzi ◽  
Flavio Rocha ◽  
Jordan Winter ◽  
Michael Pishvaian ◽  
Kabir Mody ◽  
...  
Keyword(s):  
Pancreatic Cancer ◽  
Phase 1 ◽  
Locally Advanced ◽  
Advanced Pancreatic Cancer ◽  
Locally Advanced Pancreatic Cancer

scholarly journals A phase 1 study of veliparib, a PARP-1/2 inhibitor, with gemcitabine and radiotherapy in locally advanced pancreatic cancer

EBioMedicine ◽  
2019 ◽  
Vol 40 ◽  
pp. 375-381 ◽  
Author(s):  
Richard Tuli ◽  
Stephen L Shiao ◽  
Nicholas Nissen ◽  
Mourad Tighiouart ◽  
Sungjin Kim ◽  
...  
Keyword(s):  
Pancreatic Cancer ◽  
Phase 1 ◽  
Locally Advanced ◽  
Advanced Pancreatic Cancer ◽  
Locally Advanced Pancreatic Cancer ◽  
Phase 1 Study ◽  
Parp 1

Phase 1 study of EUS-guided photodynamic therapy for locally advanced pancreatic cancer

2019 ◽  
Vol 89 (2) ◽  
pp. 390-398 ◽  
Author(s):  
John M. DeWitt ◽  
Kumar Sandrasegaran ◽  
Bert O'Neil ◽  
Michael G. House ◽  
Nicholas J. Zyromski ◽  
...  
Keyword(s):  
Pancreatic Cancer ◽  
Photodynamic Therapy ◽  
Phase 1 ◽  
Locally Advanced ◽  
Advanced Pancreatic Cancer ◽  
Locally Advanced Pancreatic Cancer ◽  
Phase 1 Study

Phase 1 dose-escalation clinical trial of EUS-guided injection of HF10 for unresectable locally advanced pancreatic cancer

Pancreatology ◽  
2016 ◽  
Vol 16 (4) ◽  
pp. S17 ◽  
Author(s):  
Yoshiki Hirooka ◽  
Hiroki Kawashima ◽  
Eizaburo Ohno ◽  
Hideki Kasuya ◽  
Maki Tanaka ◽  
...  
Keyword(s):  
Pancreatic Cancer ◽  
Clinical Trial ◽  
Dose Escalation ◽  
Phase 1 ◽  
Locally Advanced ◽  
Advanced Pancreatic Cancer ◽  
Locally Advanced Pancreatic Cancer
Sign in / Sign up

Export Citation Format

Share Document